Testimony Wraps Up In Plavix Trial

Law360, New York (February 16, 2007, 12:00 AM EST) -- After about five years spent fighting over the blood-thinner Plavix, three pharmaceutical companies inched closer to a resolution, with the trial over the drug’s patent drawing to a close on Thursday.

Instead of closing arguments, Judge Sidney H. Stein of the U.S District Court for the Southern District of New York asked attorneys for Sanofi-Aventis, Bristol-Myers Squibb Co. and Apotex Inc. to submit briefs.

The trial, which started at the end of January, pits Sanofi and Bristol-Myers against Canadian-based generic maker Apotex Inc., which launched an...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.